SLR Investment Corp.

$ 12.42 0.57 %

SLR Investment Corp. operates as a specialized investment firm, providing diverse capital solutions to leveraged middle-market businesses. The company's primary focus involves secured credit facilities, encompassing first-lien unitranche and second-lien debt, alongside junior (unsecured) debt instruments and minority equity investments. It actively participates in various corporate finance activities, including leveraged buyouts, strategic acquisitions, balance sheet recapitalizations, growth capital infusions, and general refinancing; on occasion, it also pursues strategic, income-oriented control equity positions. The firm's investment scope spans a highly diversified array of sectors such as aerospace, manufacturing, financial services, consumer goods, technology, media, and utilities, among many others. Additionally, it maintains a specialized emphasis on the life sciences, specifically targeting opportunities within specialty pharmaceuticals, medical devices, biotechnology, healthcare providers, and health technology. SLR Investment Corp. predominantly allocates its capital within the United States. Individual investment commitments typically fall between $5 million and $100 million. It targets companies with annual revenues ranging from $50 million to $1 billion and EBITDA figures between $15 million and $100 million. The company utilizes various financial instruments, including senior secured loans, mezzanine debt, and equity securities. While its equity investments are generally non-controlling, it also explores opportunities in thinly traded public companies and secondary market transactions. The firm generally aims to exit its investments within three years of the initial capital deployment.

CEO: Michael Stuart Gross - https://slrinvestmentcorp.com

Price objectif

$14.5 16.75 %

Recommandation

Buy

DCF

$ 156.85

Loading data...

SLRC vs S&P500

Loading data...

No data available.

Quick ratio

1.58

suggests a healthy liquidity position, showing that the company can likely meet its short-term obligations.

P/E ratio

7.57

may indicate that the company is undervalued or has poor growth prospects.

EPS

1.64

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

9.04 %

indicates low profitability, suggesting that the company is not using equity efficiently to generate profits.

ROIC

4.18 %

does not generate enough return to cover its financing costs, which indicates value destruction and may pose long-term profitability issues.

WACC

6.45

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

1.15

means it relies more on debt, which can increase financial risk.

Free cash flow per share

-1.68

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

99.70 %

indicates that the company is retaining a large portion of its profits to reinvest in growth

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
7 indicates good financial health
Altman score
0.48 indicates a high risk of bankruptcy
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.04 indicates liquidity risk, as the company may not have enough cash to meet its immediate obligations
Debt Ratio
0.45 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.